Ballicules.com

Pioglitazone

ACTOS

What it isPPAR-gamma agonist improving insulin sensitivity; type 2 diabetes.

Why this oneDurable A1c reduction with no hypoglycemia, and benefit in NAFLD and after stroke in insulin-resistant patients.

What limits itFluid retention and weight gain, and it precipitates heart failure. Bone fracture risk in women; onset takes weeks.

FDA-approved for

Off-label

FDA label

BOXED WARNING Thiazolidinediones, including pioglitazone, cause or exacerbate congestive heart failure; initiation contraindicated in NYHA Class III/IV heart failure.
FDA dosingPopulationStartTargetMax
Type 2 diabetes mellitusAdult15 or 30 mg QD (15 mg QD if NYHA Class I/II HF)Titrate by HbA1c45 mg QD (15 mg QD with strong CYP2C8 inhibitors, e.g., gemfibrozil)

Renal Undefined

Hepatic Obtain liver tests before starting; initiate with caution if abnormal; do not start with active liver disease

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Limited data; poorly controlled diabetes carries risk; may induce ovulation in anovulatory women.

Lactation No information on presence in human milk.

⚠ BOXED WARNING

Cost, est. cash$5–$150/month

Generic entry2012

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability3 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk0 / 4

Legacy pregnancy categoryMultiple / indication-, trimester- or formulation-dependent

Defining liabilityAgent-specific hypoglycemia, ketoacidosis, volume, renal or gastrointestinal toxicity.

Mechanism of action: Pioglitazone ballicule

Pioglitazone ballicule: receptor binding, kinetics and half-life diagram

Open Pioglitazone in the interactive console ↗

Memory aids: mascots and interaction avatars

Pioglitazone ACTOS mascot mnemonic cartoon
“Piggy glitter zone Actor”
Pioglitazone CYP2C8 substrate avatar
CYP2C8 substrate

Open Pioglitazone in the interactive console ↗